MRSi 2022: 20 Years Of Innovation In Reproductive Medicine
Taosheng Huang, MD, PhD
Taosheng Huang, MD, Ph.D, is the Chief of Genetics for Pediatrics at SUNY Buffalo, Director of Genetics & Metabolism at Oishei Children’s Hospital. His research focuses on discovering novel genes associated with mitochondrial diseases. In recent years, Dr. Huang’s group has identified many nuclear genes related to mitochondrial disease and new mtDNA mutations. For novel disease-causing genes, his group has also established and characterized disease-causing genes with both an iPS cell model and a CRISPR/Cas9 produced mouse model for a better understanding of the molecular basis of pathogenesis and to develop treatments such as gene therapy. His research on the mitochondrial replacement therapy, in collaboration with Dr. John Zhang, was among the top 10 Science stories of 2016, and the discovery on biparental mtDNA inheritance was also ranked in the top 10 publications from 2019 by Nature. Now his laboratory also applies the discoveries from rare genetic diseases to more common diseases, such as cancer, diabetes and preterm birth, and even to the biological basis of the aging process itself. He was the immediate past president of the Association of Chinese Geneticists in America (ACGA) (2018-2021). Currently, he is a board director of International Society of Reproductive Genetics.
Sessions
Working Lunch: Mitochondria In Reproductive Medicine
Saturday, June 11, 2022
12:15pm - 1:15pm CST